Will Investor Demand Lead To FOMO In the Gold Miners?

Will Investor Demand Lead To FOMO In the Gold Miners?

After recent years of consolidation, gold and precious metal mining ETFs are up about 30-40% YTD, which is a great set up for investor FOMO. To explore this possibility, the ETF Nerds have invited Otavio “Tavi” Costa into the Portfolio Manager Hot Seat during the Get Think Tanked Happy Hour. Tavi [...] READ MORE »

Are Large Cap Stocks Expensive? Lessons from Price Matters®

A forecasting tool for long-term returns: Our Price Matters® framework is a way of looking at the long-term history of stocks to get a guide as to the 10-year outlook for future returns. We do not believe it is a timing tool. [...] READ MORE »

A New Junior QQQ Provides Unique ETF Exposure

Invesco QQQ Trust (QQQ) has been one of the most popular ETFs in 2020, driven by favorable investor sentiment toward Amazon.com (AMZN), Apple (AAPL), Microsoft (MSFT) and other large-cap growth stocks in the Covid-19 driven new normal. However, the ETF misses out on many up-and-coming companies that fall outside of the top-100 [...] READ MORE »

PNQI Will Thrive Regardless of Election Results

Investors looking for assets positioned for success regardless of what happens on Election Day may want to examine internet stocks and exchange traded funds, such as the Invesco NASDAQ Internet ETF (PNQI). PNQI seeks to track the investment results (before fees and expenses) of the NASDAQ Internet Index. The fund generally will invest... READ MORE »

China Is the Elephant in the ACES Room

Renewable energy exchange traded funds, including the ALPS Clean Energy ETF (ACES), could be primed for post-election upside, but investors shouldn’t view these ETFs solely through a domestic lens. In its efforts to curb the world’s worst pollution, China is an increasingly prominent player on the global renewable energy... READ MORE »

SBIO: Weekly ALPS ETF Spotlight

While broader equity markets rallied last week, the ALPS Medical Breakthroughs ETF (SBIO) rallied over 10% to surpass its previous all-time high. Biotech stocks continue to gain momentum after President Trump touted Regeneron Pharmaceuticals (REGN; not in SBIO) monoclonal antibody to treat COVID-19, boosting [...] READ MORE »